Europe — EMA
Catalip Micronizado (Fenofibrate Micronised)
Catalip Micronizado is a medication containing Fenofibrate Micronised, used for managing lipid levels. This oral medication helps support cardiovascular health
Request sourcing
What is Fenofibrate Micronised?
Catalip Micronizado is a medication containing Fenofibrate Micronised, used for managing lipid levels. This oral medication helps support cardiovascular health by aiding in the regulation of cholesterol and triglycerides.
What is Fenofibrate Micronised used for?
Catalip Micronizado is primarily used to help lower lipid levels in the blood. It is often prescribed for individuals with high cholesterol or triglyceride levels, aiming to improve overall cardiovascular health. This medication works by reducing the production of certain fats in the liver, which can help manage conditions related to high lipid levels.
What are the side effects of Fenofibrate Micronised?
Common effects of Catalip Micronizado may include gastrointestinal discomfort, such as nausea or diarrhea. Some users might also experience muscle pain or weakness. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.
What precautions apply to Fenofibrate Micronised?
Catalip Micronizado should be used with caution in individuals with liver or kidney disease. It is important to follow the prescribed dosage and not to exceed it without medical advice. Regular monitoring of lipid levels and liver function may be recommended during treatment.
What does Fenofibrate Micronised interact with?
Catalip Micronizado may interact with certain medications, including blood thinners and other lipid-lowering drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it can affect the efficacy and safety of the medication.



